News

Sanofi and Regeneron report positive Phase 3 results for Dupixent in children with moderate-to-severe asthma

How COVID-19 is affecting those specifically with chronic conditions and how technology is helping.

Reporters at ProPublica, The Wall Street Journal and Science have written in-depth accounts of CDC's faded role, damaged reputation and White House interference.

Francois de Brantes, Otis Brawley, Eric C. Hunter, Keely Macmillan, Ateev Mehrotra, and Marc Samuels are joining the Managed Healthcare Executive® editorial advisory board.

The Johns Hopkins professor and new MHE editorial advisory board member lauds the effects of the Affordable Care Act but holds out for a program that “gets every human being the healthcare that every human being deserves,” in this second part of a four-part series.

Featured speaker at the 4th Annual PBMI Specialty Rx Forum on October 16 discusses theme of the meeting.

In this week's episode of Tuning Into The C-Suite, MHE's Briana Contreras spoke with Kate Ryder, CEO of Maven, which is the world’s largest virtual clinic for women’s and family health. In this discussion, they talked about the role of telemedicine in pregnancy care, how it impacts the prenatal model and how it will influence the patient journey post-coronavirus pandemic.

Flu increases the risk of heart attack, especially among people with diabetes and atherosclerotic cardiovascular disease (ASCVD). COVID-19 and the possibility of co-infection makes getting vaccinated against the flu particularly important this year.

Darnell Dent, principal of Dent Advisory Services and a member of the Managed Healthcare Executive® Editorial Advisory Board, discusses health disparities for people of color - specifically Blacks and Latinos - and how COVID-19 has highlighted our failure at the intersection of public health, healthcare and social justice.

Sodium glucose co-transporter 2 (SGLT2) inhibitors have already remade the diabetes drug market. Now competition for new cardiac and renal indications is heating up among three of the main drugs in the class: Janssen’s Invokana (canagliflozin), AstraZeneca’s Farxiga (dapagliflozin), and Eli Lilly/Boehringer-Ingelheim’s Jardiance (empagliflozin).

Emergency use authorization granted for CareStart point-of-care kit.

Some “don’t give a damn about their fellow man.” But in this first of four-part video series, the Johns Hopkins professor, former chief medical and scientific officer of the American Cancer Society, and MHE Editorial Advisory Board member is encouraged by diversity among protestors and the broadening of the efforts to tackle disparities of all kinds. “I think this is a long-term effort.”

The pharma maker aims to make the treatment available to the most vulnerable populations by December.

Simponi Aria is now approved to to treat patients 2 years and older with active polyarticular juvenile Idiopathic arthritis (pJIA) and psoriatic arthritis (PsA).

Johnson & Johnson pauses trial, Pfizer wants to enroll teens, and fewer Americans are willing to be vaccinated. Here's a roundup of today's news about COVID-19 vaccines.

Council for Affordable Quality Healthcare, Inc.'s solution will facilitate how health plans, Medicaid agencies and third-party apps find and share technology connections to provide consumers greater access to their healthcare data.

There's a possibility the flu shot can help protect those who receive it from COVID-19.

Central obesity may be especially unhealthy for people with the inflammatory condition that affects the spine.

Research documents that the disease affects men and women differently.

COVID-19 has accelerated the need to attract and retain patients, yet 38% of health system leaders aren't confident about their visibility into leakage.

The benefits space is changing and there is currently a shift to “enviable benefits” - ones that go beyond traditional health and retirement coverage. Many companies, especially those still doing well during the economic downturn, have ramped up benefits communication about existing support programs such as telemedicine, financial well-being and childcare.

In an interview with Axios about the first political editorial in the journal's history, Editor-in-Chief Eric Rubin says it is not an endorsement of Joe Biden but sends the message to "simply throw the bums out" and not vote for Donald Trump.

Even as many industries continue to suffer devastating setbacks due to the COVID-19 pandemic, one sector that has enjoyed an “embarrassment of profits” is health insurance.

David Lareau, CEO of Medicomp Systems, says this delay will mean ongoing challenges in access to accurate, complete data—which is more important now than ever before.

Results show an electorate deeply divided by age, gender, and partisanship.

In this week’s episode of Tuning Into the C-Suite, MHE's Briana Contreras spoke with Denise Basow, president and CEO of Clinical Effectiveness at Wolters Kluwer. Briana and Basow discussed the importance of uniting prescribers and pharmacists at the point of care and how this form of care can create more efficient and effective operations within health systems.

Experts discuss the falsehoods and half-baked ideas that are in circulation about COVID-19 transmission, treatment and equivalence to the flu.

The Max Cure Foundation is urging a dramatic reduction of toxic chemicals in the environment and within consumer products to reduce the number of children diagnosed with cancer.

The combination therapy of Opdivo plus Yervoy will treat the cancer caused by inhaling asbestos fibers.

The recall is attributed to higher levels of the carcinogenic ingredient NDMA than are allowed.